Tuttle RM - Search Results

1

Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy.

Youssef I, Yoon J, Mohamed N, Zakeri K, Press RH, Yu Y, Kang JJ, Wong RJ, Tuttle RM, Shaha A, Sherman E, Lee NY. Youssef I, et al. Among authors: tuttle rm. Int J Part Ther. 2022 Jul 15;9(2):20-30. doi: 10.14338/IJPT-22-00005.1. eCollection 2022 Fall. Int J Part Ther. 2022. PMID: 36060412 Free PMC article.

2

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin.

Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson SM. Robbins RJ, et al. Among authors: tuttle rm. Thyroid. 2001 Sep;11(9):865-9. doi: 10.1089/105072501316973127. Thyroid. 2001. PMID: 11575856

3

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.

Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Nucl Med. 2002 Nov;43(11):1482-8. J Nucl Med. 2002. PMID: 12411552 Free article.

4

Genome-wide appraisal of thyroid cancer progression.

Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Wreesmann VB, et al. Among authors: tuttle rm. Am J Pathol. 2002 Nov;161(5):1549-56. doi: 10.1016/S0002-9440(10)64433-1. Am J Pathol. 2002. PMID: 12414503 Free PMC article.

5

Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Wreesmann VB, et al. Among authors: tuttle rm. Genes Chromosomes Cancer. 2004 Aug;40(4):355-64. doi: 10.1002/gcc.20049. Genes Chromosomes Cancer. 2004. PMID: 15188460

6

Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.

Robbins RJ, Srivastava S, Shaha A, Ghossein R, Larson SM, Fleisher M, Tuttle RM. Robbins RJ, et al. Among authors: tuttle rm. J Clin Endocrinol Metab. 2004 Dec;89(12):6010-6. doi: 10.1210/jc.2003-031573. J Clin Endocrinol Metab. 2004. PMID: 15579752

7

Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer.

Rosenbluth BD, Serrano V, Happersett L, Shaha AR, Tuttle RM, Narayana A, Wolden SL, Rosenzweig KE, Chong LM, Lee NY. Rosenbluth BD, et al. Among authors: tuttle rm. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1419-26. doi: 10.1016/j.ijrobp.2005.05.043. Epub 2005 Sep 12. Int J Radiat Oncol Biol Phys. 2005. PMID: 16154712

8

Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.

Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA. Hiltzik D, et al. Among authors: tuttle rm. Cancer. 2006 Mar 15;106(6):1286-95. doi: 10.1002/cncr.21739. Cancer. 2006. PMID: 16470605 Free article.

9

Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.

Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B. Ghossein RA, et al. Among authors: tuttle rm. Cancer. 2006 Apr 15;106(8):1669-76. doi: 10.1002/cncr.21825. Cancer. 2006. PMID: 16534796 Free article.

10

Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA. Liu J, et al. Among authors: tuttle rm. Cancer. 2006 Sep 15;107(6):1255-64. doi: 10.1002/cncr.22138. Cancer. 2006. PMID: 16900519 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page